TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1

Christian C Dibble1, Winfried Elis, Suchithra Menon

  • 1Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USA.

Molecular Cell
|July 17, 2012
PubMed

Insights

Researchers identified TBC1D7 as a core subunit of the tuberous sclerosis complex (TSC) 1-2 complex. This TSC-TBC complex regulates cell growth by inhibiting mTORC1 signaling, crucial for cellular response to poor growth conditions.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Genetics

Background:

  • The tuberous sclerosis complex (TSC) 1-2 protein complex is a critical regulator of cell growth.
  • This complex functions by inhibiting the mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) pathway via GTPase-activating protein (GAP) activity towards Rheb.
  • Dysregulation of TSC/mTORC1 signaling is implicated in various cellular disorders.

Purpose of the Study:

  • To identify and characterize novel subunits of the TSC1-TSC2 complex.
  • To elucidate the functional role of TBC1D7 within the TSC complex.
  • To investigate the impact of TBC1D7 on mTORC1 signaling and cellular growth.

Main Methods:

  • Biochemical characterization of protein complexes.
  • In vitro GTPase-activating protein (GAP) assays.
  • TBC1D7 knockdown experiments using RNA interference.
  • Immunofluorescence microscopy to assess protein localization.
  • Analysis of mTORC1 signaling pathway components and autophagy induction.

Main Results:

  • TBC1D7 was identified as a stable and ubiquitous third core subunit of the TSC1-TSC2 complex, forming the functional TSC-TBC complex.
  • The TSC-TBC complex exhibits Rheb-GAP activity, essential for sensing cellular growth conditions.
  • TBC1D7 knockdown disrupted TSC1-TSC2 association, reduced Rheb-GAP activity, and led to increased mTORC1 signaling, delayed autophagy, and enhanced cell growth under nutrient-deprived conditions.
  • TBC1D7 knockdown did not affect TSC2 lysosomal localization.

Conclusions:

  • TBC1D7 is an integral component of the functional TSC complex, mediating its Rheb-GAP activity.
  • The TSC-TBC complex plays a vital role in regulating cell growth and autophagy in response to nutrient availability.
  • TBC1D7 is unlikely to be the TSC3 gene, based on sequencing analyses of TSC patient samples.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...